Peer-Review Process
After the submission of manuscripts through the website https://jmpas.com/menuscript, a unique manuscript number is generated, and all future communication with the author, reviewer, and editorial team is based on this manuscript number (jmpas/1001).
Manuscripts in “The Journal of Medical Pharmaceutical and Allied Sciences” (JMPAS) are subject to a two-part review process. The first part is the editorial review, whereby a member of the editorial team determines whether or not the article will be sent to peer review based on the quality of the research, relevancy to the journal's readership, the contribution of the work to the existing literature, quality of the writing, and timeliness of the work. All submitted manuscripts are read by the editorial team as per manuscript number. To save the time of authors and peer-reviewers. Those manuscripts that are found most likely to comply with our editorial format criteria are sent for formal review, typically with two or three reviewers as per their expertise. Those manuscripts analyzed by the editors to be of insufficient quality or otherwise inappropriate for research community benefit are rejected without external review (although these decisions may be based on informal advice from experts in the subject matter).
The second part of the review process is a single-blind peer review process with two or more reviewers, the reviewers are aware of the identity of the authors, but the authors are unaware of the identity of the reviewers. there are at least three or more reviewers for the total number of articles in each issue. Peer reviewers also complete a reviewer form and are asked to make a publication recommendation based on relevancy, originality, quality of research, quality of writing, and influence of bias. The editorial team makes a final publication decision based on the peer-review recommendations.
Sometimes special attention is needed (for example, on a new method for community benefit or a novel technique). The editors then make a note based on the expert reviewers' advice, from among all possibilities such as:
1. Accept, with or without editorial revisions.
2. Invite the authors to revise their manuscript to address specific comments before a final acceptance.
3. Reject, but encourage the authors that further necessary work might justify respective research for resubmission.
4. Reject, typically based on special interest, lack of novelty, insufficient conceptual advance, or major technical and/or quality problems.
Reviewers are free to recommend a particular course of action, but they should keep in mind that the other reviewers of a particular subject area may have different technical expertise and/or perceptions, and the editors may have to make a decision based on logical truth.
It should be noted that articles submitted by the editorial team, associate editors, board members, and guest editor of the JMPAS will also be subjected to peer review, same as other authors, and the editorial manager not have a role in the review or decision.
Transparent peer review
The peer review process is applied to all published articles, authors are provided the opportunity into this process of peer review, before the manuscript is accepted. Although we hope that the peer review comments will provide a detailed and useful view to the authors. It is important to note that these files with comments will not contain all the information considered in the editorial decision-making process, such as the discussion to recommend a particular course of action, but they should keep in mind that the other reviewers of a particular subject area may have different technical expertise and/or perceptions, and the editors may have to make a decision based on logical truth.
It should be noted that articles submitted by the editorial team, associate editors, board members, and guest editor of the JMPAS will also be subjected to peer review, same as other authors, and the editorial manager not have a role in the review or decision.
Transparent peer review between the editorial manager and any confidential comments made by reviewers or authors to the editorial team.
All submissions are subject to applicable provisions of ICMJE, ISSN, and the Committee on Publication Ethics, and publication may be withdrawn or denied at any time consistent with those provisions. Members of the editorial team rescue themselves from editorial decisions if they have conflicts of interest or pose potential conflicts related to articles under consideration.
“Journal of Medical Pharmaceutical and Allied Sciences” (JMPAS) by Medic scientific publisher committed to rapid editorial decisions and publication, and we believe that an efficient peer review process is a valuable service both to our authors and to the scientific community. We, therefore, ask respective reviewers to respond as soon as possible or within the days agreed. If reviewers anticipate a longer delay than expected, we ask them to let us know so that we can keep the authors informed and, action by the editorial team to appoint another reviewer.